Compugen CMO Michelle Mahler Receives Equity Awards

What Happened

• Michelle Mahler, Chief Medical Officer of Compugen Ltd (CGEN), received equity awards on July 29, 2026: 13,500 restricted stock units (RSUs) and 18,000 option-type awards. Both awards were granted at $0.00 (no cash paid), for a total of 31,500 units/rights granted.

Key Details

• Transaction date: 2026-07-29; Form 4 filed 2026-07-30 (filed one business day after the transaction).
• Prices reported: $0.00 for both grants (awards/compensation, not open-market purchases).
• Shares owned after the transaction: not reported in this filing.
• Footnotes: F1 = 13,500 RSUs vest 25% on 2027-09-30, then the remainder vests in 12 equal quarterly installments subject to continued service. F2 = the 18,000 award is an option that vests 25% on 2027-09-30, then the remainder vests in 12 equal quarterly installments subject to continued service.
• No indication in the filing of a 10b5-1 plan, tax-withholding sale, or immediate cashless exercise.

Context

• These grants are compensation awards that vest over time and depend on Mahler’s continued service; they are not open-market purchases or sales and therefore do not directly indicate a near-term trading view. The option-type award will become exercisable according to the stated vesting schedule; the RSUs convert to shares as they vest.